MedPath

NIRS vs TCD for Cerebrovascular Autoregulation During Non-cardiac Surgery

Completed
Conditions
Cerebrovascular Circulation
Registration Number
NCT04978558
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Brief Summary

Postoperative neurocognitive disorders (NCD) are of high priority in perioperative management. The risk of suffering from NCD after surgery may be increased due to perioperative impairment of cerebrovascular autoregulation and thereby inadequate cerebral perfusion. Cerebrovascular autoregulation refers to the ability of cerebral arterioles to ensure constant cerebral blood flow independently of fluctuations in systemic blood pressure.

Cerebrovascular autoregulation can be measured based on mean arterial pressure (MAP) and a surrogate for cerebral blood flow using the correlation method. Until today, measurement of cerebral blood flow velocity assessed with transcranial Doppler sonography (TCD) is most commonly used as a non-invasive surrogate for cerebral blood flow. Alternatively, cerebral oxygenation measured with near-infrared spectroscopy (NIRS) can be used as another surrogate.

The study includes three substudies:

1. To compare NIRS and TCD for the assessment of perioperative cerebrovascular autoregulation in patients undergoing major non-cardiac surgery with an increased risk of bleeding.

2. To compare MAP for optimal cerebrovascular autoregulation before induction of general anesthesia with MAP for optimal cerebrovascular autoregulation during or after general anesthesia.

3. To analyze the association between the time-weighted average MAP below the MAP for optimal cerebrovascular autoregulation and postoperative NCD.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
509
Inclusion Criteria
  • Age ≥ 18 years
  • Elective surgery with a minimum duration of 120 minutes
  • General anesthesia
  • expected blood loss > 500 ml
Exclusion Criteria
  • Temporal bone window failure (substudy 1)
  • Cerebrovascular disease
  • Cardiac surgery
  • Neurosurgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Equivalence of NIRS-based and TCD-based intraoperative measurement of cerebrovascular autoregulationup to 4 hours during surgery

calculation of cerebral autoregulation indices based on near-infrared spectroscopy and transcranial Doppler sonography

optimal MAP during NIRS-based measurement of cerebrovascular autoregulationup to 2 hours after surgery

MAP at lowest cerebral autoregulation index COx

delirium and postoperative NCD after surgery (composite)days 1 to 4 after surgery (delirium), day 7 after surgery or at day of discharge from hospital (NCD)

screening for postoperative delirium; neuropsychological testing for the assessment of cognitive function

Secondary Outcome Measures
NameTimeMethod
optimal MAP during TCD-based measurement of cerebrovascular autoregulationup to 4 hours during surgery

MAP at lowest cerebral autoregulation index (Mx)

postoperative delirium between day 1 and 4 after surgerydays 1 to 4 after surgery

screening for postoperative delirium

delayed neurocognitive recovery at day 7 after surgery or before hospital dischargeday 7 after surgery or at day of discharge from hospital

neuropsychological assessment

length of hospital staydate of discharge from hospital (up to 30 days)

duration of hospital stay (in days) between surgery and discharge

length of ICU staydate of discharge from ICU (up to 30 days)

duration of intensive care unit stay (in days) between surgery and discharge

mortality at 3 months after surgery3 months after surgery

survival status three months after surgery

Trial Locations

Locations (1)

Department of Anesthesiology, University Medical Center Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

Department of Anesthesiology, University Medical Center Hamburg-Eppendorf
🇩🇪Hamburg, Germany
Marlene Fischer, MD, PhD
Contact
+4915222827500
mar.fischer@uke.de
Ursula Kahl, MD
Sub Investigator
Bernd Saugel, MD, Prof
Sub Investigator
Katrin Brodersen, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.